Transplant News and Research

RSS

Massachusetts General Hospital implants Levacor Ventricular Assist Device

World Heart Corporation, a developer of mechanical circulatory systems, announced today that the Massachusetts General Hospital in Boston, Mass. has successfully implanted its first Levacor™ Ventricular Assist Device (VAD). Mass General is the fifth implanting site nationwide in the Levacor VAD Bridge-to-Transplant (BTT) Study. This is the eleventh implant with the Levacor VAD since the inception of the BTT study.

16 Aug 2010

Pathology experts meet to at SESPM to update new advances in breast surgery

Over 1.500 breast pathology experts will meet between the 20th and 22nd of October in the 16th World Congress of the Senologic International Society (SIS). This meeting and the 29th Congress of the Spanish Society of Senology and Breast Diseases (SESPM) will take place in the Valencia, coinciding with the International Breast Cancer Day.

16 Aug 2010

Belatacept study data to be presented at 23rd International Congress of The Transplantation Society

Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of seven oral clinical presentations related to kidney transplantation at the 23rd International Congress of The Transplantation Society, being held August 15-19, 2010, in Vancouver, British Columbia, Canada. In total, 18 abstracts from company-sponsored studies will be presented during the congress.

16 Aug 2010

Canada's low deceased organ donation rate not due to lack of public support

While more than 4,000 Canadians are on wait lists for organ transplants - and every day-and-a-half, one patient dies waiting - Canada's low deceased organ donation rate cannot be attributed to a lack of public support.

16 Aug 2010

New T cell engineering approach can improve success rate of immune-cell therapies

Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.

16 Aug 2010

Kibow to support KDAE week for educating policymakers about kidney disease

Kibow Biotech would like to show its support for Kidney Disease Awareness and Education (KDAE) Week 2010, organized by American Nephrology Nurses' Association (ANNA). Kidney Disease Awareness and Education Week is a week dedicated to educating policymakers and their staff members about the needs of patients suffering from or at risk for end stage renal disease (ESRD).

13 Aug 2010

FDA grants LifeCycle Pharma SPA for LCP-Tacro pivotal Phase 3 study in 'de novo' kidney transplant patients

LifeCycle Pharma A/S today announced receipt of agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment of its pivotal Phase 3 study, Study 3002, for LCP-Tacro in patients, who have just received a kidney transplant.

12 Aug 2010

Gentium second-quarter total revenues increase to EUR 7.55 million

Gentium S.p.A. today reported financial results for the first half of 2010 and for the quarter ended June 30, 2010. The Company reports its financial condition and operating results using U.S. Generally Accepted Accounting Principles (GAAP). The Company's financial statements are prepared using the Euro as its functional currency.

12 Aug 2010

NYBC calls for blood donations

New York Blood Center, serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to remember your neighbors during this slow, late summer period for blood donations – and schedule a donation appointment or consider sponsoring a blood drive, because patients' needs do not take a summer break.

12 Aug 2010

Tengion announces clinical, corporate and second-quarter financial updates

Tengion Inc. today provided a corporate and product development update and reported its financial results for the quarter ended June 30, 2010.

12 Aug 2010

SynCardia Systems launches new online store

On Aug. 11, SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced the launch of its new online store, http://Shop.SynCardia.com. SynCardia is the first company in the mechanical circulatory support industry to make its products available to customers through an e-commerce site 24/7.

12 Aug 2010

Einstein College receives grant to develop stem cell-based therapies

Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome - part of acute radiation syndrome (ARS) - for military personnel, first responders and the general public. The Einstein research, funded by the federal Centers for Medical Countermeasures Against Radiation, is part of a program coordinated by the National Institute of Allergy and Infectious Diseases.

12 Aug 2010

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.

11 Aug 2010

NMDP applauds introduction of 'Stem Cell Therapeutic and Research Reauthorization Act of 2010'

The National Marrow Donor Program today applauded the introduction of the "Stem Cell Therapeutic and Research Reauthorization Act of 2010." Sens. Orrin Hatch (R-UT), Christopher Dodd (D-CT), Richard Burr (R-NC), Jack Reed (D-RI), John Ensign (R-NV), and Al Franken (D-MN) introduced the act in the U.S. Senate as S. 3751 on Thursday, Aug. 5. Last evening, Reps. C.W. Bill Young (R-FL) and Doris Matsui (D-CA) introduced the companion legislation, (H.R. 6081), in the House.

11 Aug 2010

UC Health University Hospital to incorporate MRO's ROI technology with existing EMR system

MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced a contract with UC Health University Hospital (Cincinnati, Ohio) to provide ROI processing services to the facility. Under this agreement, University Hospital will incorporate MRO's ROI technology with its existing electronic medical record system. The new workflow enables the organization to bring its ROI process in-house and partner with MRO to provide the back-office fulfillment functions.

11 Aug 2010

Methodist Healthcare System to implement TeleTracking Technologies' RadarFind RTLS

Citing superior accuracy and performance, the Methodist Healthcare System, San Antonio, TX, has selected TeleTracking Technologies' RadarFind real-time locating system to track thousands of assets, and eventually patients, across multiple facilities.

11 Aug 2010

NKTreg white blood cells migrate into liver, suppress immune responses: Research

After a transplant - and to assure that the new organ is not rejected - patients are put on life-long therapy to suppress their immune system, which, nevertheless, needs to be left intact enough to be able to defend the body against all kinds of disease. A tricky balance as the many rejected organs attest. But a discovery by Maria Monteiro and Luis Graça, two Portuguese scientists, could change all this, at least for the liver.

11 Aug 2010

Bluhm Cardiovascular Institute implants two Heartware ventricular assist devices

The Bluhm Cardiovascular Institute of Northwestern Memorial Hospital recently implanted a patient with two of the smallest experimental ventricular assist devices (VADs) currently available for study in humans. VADs are designed to assist either the right (RVAD) or left (LVAD) ventricle, or both (BiVAD) at once. This is the first time that two Heartware VADs have been implanted in the left and right ventricles anywhere in North America—a "game changer" in the realm of heart assist devices according to Patrick M. McCarthy, MD, chief of the hospital's division of cardiac surgery and director of the hospital's Bluhm Cardiovascular Institute.

11 Aug 2010

Stanford Hospital & Clinics establishes Kidney and Pancreas Transplant Clinic at Salinas Valley Memorial

The partnership between Salinas Valley Memorial Healthcare System and Stanford Hospital & Clinics has added another facet of care, bringing world-class organ transplant care to patients on the Central Coast. Stanford's Adult Kidney and Pancreas Transplant Program will begin seeing patients at Salinas Valley Memorial's Ryan Ranch facility.

11 Aug 2010

Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma

Genmab A/S announced today top-line interim results from an initial Phase II single arm open label study of ofatumumab to evaluate the treatment of relapsed Diffuse Large B-Cell Lymphoma in patients ineligible for or relapsed following a stem cell transplant.

11 Aug 2010

Transplant News and Research

Massachusetts General Hospital implants Levacor Ventricular Assist Device

Pathology experts meet to at SESPM to update new advances in breast surgery

Belatacept study data to be presented at 23rd International Congress of The Transplantation Society

Canada's low deceased organ donation rate not due to lack of public support

New T cell engineering approach can improve success rate of immune-cell therapies

Kibow to support KDAE week for educating policymakers about kidney disease

FDA grants LifeCycle Pharma SPA for LCP-Tacro pivotal Phase 3 study in 'de novo' kidney transplant patients

Gentium second-quarter total revenues increase to EUR 7.55 million

NYBC calls for blood donations

Tengion announces clinical, corporate and second-quarter financial updates

SynCardia Systems launches new online store

Einstein College receives grant to develop stem cell-based therapies

HemaQuest commences HQK-1004 global Phase 2 clinical trial in EBV-related malignancies

NMDP applauds introduction of 'Stem Cell Therapeutic and Research Reauthorization Act of 2010'

UC Health University Hospital to incorporate MRO's ROI technology with existing EMR system

Methodist Healthcare System to implement TeleTracking Technologies' RadarFind RTLS

NKTreg white blood cells migrate into liver, suppress immune responses: Research

Bluhm Cardiovascular Institute implants two Heartware ventricular assist devices

Stanford Hospital & Clinics establishes Kidney and Pancreas Transplant Clinic at Salinas Valley Memorial

Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News